1. Home
  2. ABVC vs AQMS Comparison

ABVC vs AQMS Comparison

Compare ABVC & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVC
  • AQMS
  • Stock Information
  • Founded
  • ABVC 2015
  • AQMS 2014
  • Country
  • ABVC United States
  • AQMS United States
  • Employees
  • ABVC N/A
  • AQMS N/A
  • Industry
  • ABVC Biotechnology: Pharmaceutical Preparations
  • AQMS Metal Fabrications
  • Sector
  • ABVC Health Care
  • AQMS Industrials
  • Exchange
  • ABVC Nasdaq
  • AQMS Nasdaq
  • Market Cap
  • ABVC 16.7M
  • AQMS 11.1M
  • IPO Year
  • ABVC N/A
  • AQMS 2015
  • Fundamental
  • Price
  • ABVC $1.31
  • AQMS $1.05
  • Analyst Decision
  • ABVC
  • AQMS Strong Buy
  • Analyst Count
  • ABVC 0
  • AQMS 3
  • Target Price
  • ABVC N/A
  • AQMS $21.00
  • AVG Volume (30 Days)
  • ABVC 213.2K
  • AQMS 85.9K
  • Earning Date
  • ABVC 04-30-2025
  • AQMS 05-08-2025
  • Dividend Yield
  • ABVC N/A
  • AQMS N/A
  • EPS Growth
  • ABVC N/A
  • AQMS N/A
  • EPS
  • ABVC N/A
  • AQMS N/A
  • Revenue
  • ABVC $508,383.00
  • AQMS N/A
  • Revenue This Year
  • ABVC $735.18
  • AQMS N/A
  • Revenue Next Year
  • ABVC N/A
  • AQMS $550.00
  • P/E Ratio
  • ABVC N/A
  • AQMS N/A
  • Revenue Growth
  • ABVC 1904.43
  • AQMS N/A
  • 52 Week Low
  • ABVC $0.40
  • AQMS $1.05
  • 52 Week High
  • ABVC $1.40
  • AQMS $10.44
  • Technical
  • Relative Strength Index (RSI)
  • ABVC 71.45
  • AQMS 27.79
  • Support Level
  • ABVC $1.01
  • AQMS $1.05
  • Resistance Level
  • ABVC $1.00
  • AQMS $1.37
  • Average True Range (ATR)
  • ABVC 0.09
  • AQMS 0.10
  • MACD
  • ABVC 0.03
  • AQMS -0.02
  • Stochastic Oscillator
  • ABVC 92.78
  • AQMS 8.16

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

Share on Social Networks: